1002 related articles for article (PubMed ID: 8751444)
1. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
Samson M; Libert F; Doranz BJ; Rucker J; Liesnard C; Farber CM; Saragosti S; Lapoumeroulie C; Cognaux J; Forceille C; Muyldermans G; Verhofstede C; Burtonboy G; Georges M; Imai T; Rana S; Yi Y; Smyth RJ; Collman RG; Doms RW; Vassart G; Parmentier M
Nature; 1996 Aug; 382(6593):722-5. PubMed ID: 8751444
[TBL] [Abstract][Full Text] [Related]
2. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.
Balotta C; Bagnarelli P; Violin M; Ridolfo AL; Zhou D; Berlusconi A; Corvasce S; Corbellino M; Clementi M; Clerici M; Moroni M; Galli M
AIDS; 1997 Aug; 11(10):F67-71. PubMed ID: 9256936
[TBL] [Abstract][Full Text] [Related]
3. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
[TBL] [Abstract][Full Text] [Related]
4. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
[TBL] [Abstract][Full Text] [Related]
5. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
Furci L; Scarlatti G; Burastero S; Tambussi G; Colognesi C; Quillent C; Longhi R; Loverro P; Borgonovo B; Gaffi D; Carrow E; Malnati M; Lusso P; Siccardi AG; Lazzarin A; Beretta A
J Exp Med; 1997 Aug; 186(3):455-60. PubMed ID: 9236198
[TBL] [Abstract][Full Text] [Related]
6. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
7. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
Liu R; Paxton WA; Choe S; Ceradini D; Martin SR; Horuk R; MacDonald ME; Stuhlmann H; Koup RA; Landau NR
Cell; 1996 Aug; 86(3):367-77. PubMed ID: 8756719
[TBL] [Abstract][Full Text] [Related]
8. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
Dean M; Carrington M; Winkler C; Huttley GA; Smith MW; Allikmets R; Goedert JJ; Buchbinder SP; Vittinghoff E; Gomperts E; Donfield S; Vlahov D; Kaslow R; Saah A; Rinaldo C; Detels R; O'Brien SJ
Science; 1996 Sep; 273(5283):1856-62. PubMed ID: 8791590
[TBL] [Abstract][Full Text] [Related]
9. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
McNicholl JM; Smith DK; Qari SH; Hodge T
Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
[TBL] [Abstract][Full Text] [Related]
10. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.
Michael NL; Chang G; Louie LG; Mascola JR; Dondero D; Birx DL; Sheppard HW
Nat Med; 1997 Mar; 3(3):338-40. PubMed ID: 9055864
[TBL] [Abstract][Full Text] [Related]
11. Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.
Gorry PR; Zhang C; Wu S; Kunstman K; Trachtenberg E; Phair J; Wolinsky S; Gabuzda D
Lancet; 2002 May; 359(9320):1832-4. PubMed ID: 12044382
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].
Motta P; Cibulsky L; Iliovich E; Habegger de Sorrentino A
Medicina (B Aires); 2000; 60(4):431-4. PubMed ID: 11188946
[TBL] [Abstract][Full Text] [Related]
13. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
Wu L; Paxton WA; Kassam N; Ruffing N; Rottman JB; Sullivan N; Choe H; Sodroski J; Newman W; Koup RA; Mackay CR
J Exp Med; 1997 May; 185(9):1681-91. PubMed ID: 9151905
[TBL] [Abstract][Full Text] [Related]
14. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity.
Rucker J; Samson M; Doranz BJ; Libert F; Berson JF; Yi Y; Smyth RJ; Collman RG; Broder CC; Vassart G; Doms RW; Parmentier M
Cell; 1996 Nov; 87(3):437-46. PubMed ID: 8898197
[TBL] [Abstract][Full Text] [Related]
15. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
Huang Y; Paxton WA; Wolinsky SM; Neumann AU; Zhang L; He T; Kang S; Ceradini D; Jin Z; Yazdanbakhsh K; Kunstman K; Erickson D; Dragon E; Landau NR; Phair J; Ho DD; Koup RA
Nat Med; 1996 Nov; 2(11):1240-3. PubMed ID: 8898752
[TBL] [Abstract][Full Text] [Related]
16. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
[TBL] [Abstract][Full Text] [Related]
17. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice.
Picchio GR; Gulizia RJ; Mosier DE
J Virol; 1997 Sep; 71(9):7124-7. PubMed ID: 9261448
[TBL] [Abstract][Full Text] [Related]
19. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
Simmons G; Wilkinson D; Reeves JD; Dittmar MT; Beddows S; Weber J; Carnegie G; Desselberger U; Gray PW; Weiss RA; Clapham PR
J Virol; 1996 Dec; 70(12):8355-60. PubMed ID: 8970955
[TBL] [Abstract][Full Text] [Related]
20. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion.
Picard L; Simmons G; Power CA; Meyer A; Weiss RA; Clapham PR
J Virol; 1997 Jul; 71(7):5003-11. PubMed ID: 9188565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
